SmPC- Atenolol 25mg Tablets: Change history
View Summary of Product Characteristics (SmPC- Atenolol 25mg Tablets)
Last updated on this site: 16 Feb 2026
Update to SPC sections 4.4, 4.5, and PIL in line with PSUSA/00000259/202502 recommendations for an increased risk of hypoglycaemia, and the concomitant use of beta-blockers and sulfonylureas.
Approval date 07/02/2026.
SmPC sections updated 4.4, 4.5 and 10.
PIL sections updated Heading, 2 and 6.
View Summary of Product Characteristics (SmPC- Atenolol 25mg Tablets)
Last updated on this site: 16 Feb 2026
Update to SPC sections 4.4, 4.5, and PIL in line with PSUSA/00000259/202502 recommendations for an increased risk of hypoglycaemia, and the concomitant use of beta-blockers and sulfonylureas.
Approval date 07/02/2026.
SmPC sections updated 4.4, 4.5 and 10.
PIL sections updated Heading, 2 and 6.
-
Changes: (Updated: 16 Feb 2026)
Update to SPC sections 4.4, 4.5, and PIL in line with PSUSA/00000259/202502 recommendations for an increased risk of hypoglycaemia, and the concomitant use of beta-blockers and sulfonylureas.
Approval date 07/02/2026.
SmPC sections updated 4.4, 4.5 and 10.
PIL sections updated Heading, 2 and 6.
-
Changes: (Updated: 20 Sep 2022)
Linked to amended product entry
-
Changes: (Updated: 15 Sep 2022)
Initial upload